Clinical Trials Logo

RET Gene Mutation clinical trials

View clinical trials related to RET Gene Mutation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03784378 Completed - Ovarian Cancer Clinical Trials

Continued Access to RXDX-105

Start date: December 14, 2018
Phase: Phase 1
Study type: Interventional

This study is being done to see if people with Non-Small Cell Lung Cancer (NSCLC) or ovarian cancer benefit from continued treatment with the study drug, RXDX-105.